In vitro evidence for the presence of [3H]-haloperidol uptake in rat brain

Br J Pharmacol. 2003 Jan;138(1):188-92. doi: 10.1038/sj.bjp.0705009.

Abstract

1 The neuroleptic [(3)H]-haloperidol (HP) was taken up in synaptosomes prepared from rat brain, in a temperature-, sodium ion-, and energy-dependent process. 2 The highest concentration of uptake sites (V(max)=2.37 pmol mg(-1) protein min(-1)) was in the striatum with the other brain areas displaying lower (by 50-70%) values. 3 The affinity values (K(m) approximately equal to 40 nM) were similar in all brain areas considered. 4 The pharmacological characterization did not indicate a well-defined group of inhibitors, which suggested that HP might not use a transporter for recognized neurotransmitters. 5 The HP metabolites tested, including HPTP, were competitive inhibitors of [(3)H]-HP uptake, an indirect indication that they may actively enter the striatal nerve endings through the same carrier. 6 Since the uptake process was partially affected by the incubation of [(3)H]-HP in the presence of several antagonists of HP-transforming cytochrome P450 isoforms, the binding of HP at some enzyme sites inside the synaptosome cannot be excluded. 7 In conclusion, the present results suggest that HP may be actively transported in the rat brain.

MeSH terms

  • Animals
  • Brain / metabolism*
  • Dose-Response Relationship, Drug
  • Haloperidol / metabolism*
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Synaptosomes / metabolism
  • Tritium / metabolism*

Substances

  • Tritium
  • Haloperidol